Congenital Heart Disease Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
New to F1000? See this week’s top article below for a free preview of a Recommendation.
- » Anomalies of coronary arteries
- » Arrhythmias related to congenital abnormalities
- » Cyanotic heart defects with high pulmonary flow and pressure
- » Double-outlet right or left ventricle and variants: defects associated with heterotaxy/isomerism
- » Hypoplastic left or right heart syndrome
- » Interventional catheter treatment of congenital heart disease
- » Left to right shunts
- » Non-complex cyanotic defects (e.g. Fallot's tetralogy, transposition, pulmonary atresia with VSD, TAPVD)
- » Pediatric cardiomyopathy, inherited and metabolic disorders of heart muscle
- » Psychosocial aspects of congenital heart disease
- » Simple obstructive defects (e.g. aortic stenosis, pulmonary stenosis, coarctation)
This study identifies a previously unidentified role for the Prdm1 transcriptional repressor in the mesoderm of the second heart field (SHF), an important source of cardiac progenitor cells. Congenital heart defects represent a major human...
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
4 Recommendations, most recent by| Interesting Hypothesis | New Finding | Technical Advance
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.Subscribe for $9.95/month
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.Recommend to your Librarian
If you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.Request an Institutional Trial
your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.